US government agency to investigate FDA over rofecoxib.
Lenzer
Jeanne
J
D017277:Drug Approval; D006801:Humans; D007400:Interprofessional Relations; D007783:Lactones / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000139:chemically induced*; D020521:Stroke / Q000139:chemically induced*; D013450:Sulfones; D014481:United States; D014486:United States Food and Drug Administration
D007783:Lactones; D013450:Sulfones; C116926:rofecoxib